# First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-nivolumab-plus-ipilimumab-in-unresectable-malignant-pleural/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul Baas,Arnaud Scherpereel,Anna K. Nowak,Nobukazu Fujimoto,Solange Peters,Anne S. Tsao,Aaron S. Mansfield,Sanjay Popat,Thierry Jahan,Scott Antonia,Youssef Oulkhouir,Yolanda Bautista,Robin Cornelissen,Laurent Greillier,Francesco Grossi,Dariusz M. Kowalski,Jerónimo Rafael Rodríguez‐Cid,Praveen Aanur,Abderrahim Oukessou,Christine Baudelet,Gérard Zalcman |
| Citations | 1,212 |
| DOI | 10.1016/s0140-6736(20)32714-8 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://research-repository.uwa.edu.au/en/publications/222c004f-d1f5-493d-a0c4-2fd6571fab1b |
| OpenAlex ID | https://openalex.org/W3122627530 |
| PMID | 33485464 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Aaron S. Mansfield](https://scholariq.org/researchers/aaron-s-mansfield/)
- [Nobukazu Fujimoto](https://scholariq.org/researchers/nobukazu-fujimoto/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

## Paper topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.